NCT04096989

Brief Summary

Prediabetes is a major risk factor for diabetes. The Lifestyle Modification Mobile Health Application (APP) could not only help to decrease blood sugar among individuals with prediabetes but it could also prevent a later occurrence of diabetes. While many people use traditional Chinese medicine (TCM) to improve the participants body constitution in Chinese culture, it rarely if ever obtained through a mobile device. There are very few apps that provide effective TCM regimen-based lifestyle advice for prediabetes. Therefore, the investigators want to develop and evaluate the effectiveness of receiving TCM regimen-based lifestyle advice from a mobile device designed to improve the applicant's health status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 20, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

February 17, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

August 30, 2022

Status Verified

August 1, 2021

Enrollment Period

1.3 years

First QC Date

September 10, 2019

Last Update Submit

August 25, 2022

Conditions

Keywords

prediabetesTCMbody constitutionmeridian energyAPP

Outcome Measures

Primary Outcomes (5)

  • Meridian energy of Meridian energy device

    The meridian energy device captures data regarding the individual's balance of meridian energy. Balance was measured by the values of physical, metabolism, musculoskeletal and circulation, mental health, and autonomic nervous system status ratios. To achieve the appropriate balance for the energy results, a ratio of close to one was preferred.

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Body constitution of body constitution questionnaire (BCQ)

    The scale range from 44 to 220, with higher scores indicating larger deficiencies

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Blood sugar control of fasting plasma glucose (FPG)

    The normal range of FPG from 70-99mg/dL.

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Blood sugar control of HbA1c

    The normal range of HbA1c from 4-5.6%.

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Health-related quality of life of short form 36 (SF-36)

    The scale range from 0 to 100, with higher scores indicating better quality of life

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

Secondary Outcomes (3)

  • Physical activity of international physical activity questionnaire self-administered short version (IPAQ-SS)

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Dietary behavior of the dietary behavior questionnaire

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

  • Body mass index (BMI)

    Change before, through intervention completion (average of 3 months)and after 1 month intervention.

Study Arms (3)

Control group

NO INTERVENTION

Routine care.

Experimental group

EXPERIMENTAL

The participants accept TCM regimen-based lifestyle mobile health application intervention.

Other: Traditional Chinese medicine regimen-based lifestyle mobile health APP

Sham comparator group

SHAM COMPARATOR

The participants accept mobile health application intervention.

Other: Lifestyle mobile health APP

Interventions

The Experimental group receives TCM regimen-based lifestyle mobile health application intervention.

Experimental group

Sham comparator group receives mobile health application, but there is no traditional Chinese medicine information.

Sham comparator group

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Previously diagnosed with prediabetes with an HbA1c of 5.7% to 6.4% and an FPG level of 100 mg/dl to \< 126 mg/dl (ADA, 2011, 2014).
  • Aged 20 and above.
  • Provided informed consent.

You may not qualify if:

  • Use of hypoglycemic agent,βblocker, thiazide diuretics, nicotinic acid or steroids within the past 3 months.
  • Self-reported catastrophic illness in the last 6 months (e.g. stroke, cardiovascular disease, renal and liver insufficiency, heart failure, chronic obstructive pulmonary disease and cancer).
  • Endocrine diseases like hyperthyroidism or autoimmune disease.
  • Psychosis or other major neurocognitive disorder; (e) pregnancy and/or lactation.
  • (f) Individuals with pacemakers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Tzu Chi Hospital

New Taipei City, 231, Taiwan

Location

Related Publications (1)

  • Chung HW, Tai CJ, Chang P, Su WL, Chien LY. The Effectiveness of a Traditional Chinese Medicine-Based Mobile Health App for Individuals With Prediabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2023 Jun 20;11:e41099. doi: 10.2196/41099.

MeSH Terms

Conditions

Prediabetic State

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2019

First Posted

September 20, 2019

Study Start

February 17, 2020

Primary Completion

May 20, 2021

Study Completion

May 31, 2021

Last Updated

August 30, 2022

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations